Baird Financial Group’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-14,785
Closed -$4.04M 1534
2019
Q3
$4.04M Buy
+14,785
New +$4.04M 0.02% 569
2019
Q2
Sell
-6,653
Closed -$3.37M 1547
2019
Q1
$3.37M Buy
+6,653
New +$3.37M 0.02% 539
2018
Q4
Sell
-1,025
Closed -$873K 1329
2018
Q3
$873K Buy
1,025
+5
+0.5% +$4.26K 0.01% 887
2018
Q2
$747K Buy
1,020
+378
+59% +$277K 0.01% 903
2018
Q1
$1.02M Buy
+642
New +$1.02M 0.01% 818